About Karen White

This author has not yet filled in any details.
So far Karen White has created 182 blog entries.

Kentucky

HB 342, legislation that would require all controlled substance prescriptions to be e-prescribed, passed the House of Representatives. The bill was subsequently referred to the Senate Health and Welfare Committee, was amended with a clarification to one of the exemptions, was favorably reported and referred to the Senate Rules Committee.

For more information, contact NACDS’ Jill McCormack at 717-592-8977.

2019-03-19T13:42:19-04:00March 14, 2019|Kentucky|

Iowa

Gov. Kim Reynolds(R) appointed Kathy Stone, PharmD, and Dane Nealson, CPhT, to the Board of Pharmacy. Dane Nealson is the first technician to serve on the Board. Lawyer Joan Skogstrom was also reappointed.

Also in Iowa, the Board of Pharmacy delayed the effective date for its final rulesamending minimum requirements for participation in statewide protocols. The rules are now effective Wednesday, May 15.

For more information, contact NACDS’ Joel Kurzman at 847-905-0555.

2019-03-19T13:40:28-04:00March 14, 2019|Iowa|

Arkansas

SB 174, legislation NACDS promoted, mandating e-prescribing of controlled substance prescriptions, was signed into law by Gov. Asa Hutchinson (R) and is now Act 447.

For more information, contact NACDS’ Mary Staples at 817-442-1155.

2019-03-19T13:38:15-04:00March 14, 2019|Arkansas|

Wyoming

On February 28, Gov. Mark Gordon (R) signed into law SF 47, requiring mandatory e-prescribing of controlled substance prescriptions on and after Friday, January 1, 2021, and including provisions to permit the Board of Pharmacy to provide exemptions from the requirements for emergencies and technical failures by rule and regulation. Among the various provisions, this newly enacted law also includes continuing education requirements for prescribers and pharmacists. Pharmacists who are registered to dispense controlled substances will be required to complete one hour of CE every two years related to the responsible prescribing of controlled substances or the treatment of substance abuse disorders.

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.

2019-03-27T07:50:48-04:00March 8, 2019|Wyoming|

Washington

 Second Substitute HB 1331, Gov. Jay Inslee’s (D) opioid legislation, is headed for the House floor with amendments mandating e-prescribing of controlled substance prescriptions by Friday, January 1, 2021. The bill still has to pass the Senate.

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.

2019-03-19T13:21:49-04:00March 8, 2019|Washington|

Florida

Effective Monday, March 18, Medicaid paper exceptional claims will no longer be accepted. Providers must submit an exceptional claim, along with the required Exceptional Claim Form, electronically via the newly redesigned Florida Medicaid Secure Web Portal under the Claims panel. Providers are encouraged to review the Electronic Exceptional Claim Submission Quick Reference Guide.

For more information, contact NACDS’ Leigh Knotts at 803-243-7207.

2019-03-19T13:19:19-04:00March 8, 2019|Florida|

Arkansas

NACDS-backed SB 174, which mandates e-prescribing of controlled substance prescriptions and passed the Senate last week, was approved by the House and sent to Gov. Asa Hutchinson (R) to sign into law, effective Friday, January 1, 2021. Thanks to the sponsors of the legislation, Sen. Kim Hammer (R) and Rep. Justin Boyd (R), and the governor’s drug czar, Kirk Lane, who was instrumental in getting this legislation passed.

For more information, contact NACDS’ Mary Staples at 817-442-1155.

2019-03-19T13:17:16-04:00March 8, 2019|Arkansas|

Washington

Although SB 5446, the stand-alone e-prescribing bill did not make it through the first cut-off and will not advance, NACDS and partners will continue to work to add e-prescribing amendments onto HB 1331 / SB 5380, companion bills related to opioid use disorder treatment, prevention and related services.

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.

2019-03-19T13:26:07-04:00March 1, 2019|Washington|

Texas

The Health and Human Services Commission is seeking input on their latest draft specialty drug list for the first quarter of 2019. Comments must be submitted by Friday, March 8.

For more information, contact NACDS’ Mary Staples at 817-442-1155.

2019-03-19T13:28:25-04:00March 1, 2019|Texas|
Go to Top